                         SEQUENCE LISTING

<110>  BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
 
<120>  HLA-RESTRICTED VCX/Y PEPTIDES AND T CELL RECEPTORS AND USE 
       THEREOF

<130>  UTFC.P1475WO

<140>  Filed Concurrently Herewith
<141>  2020-10-16

<150>  US 62/923,228
<151>  2019-10-18

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  1

Ala Ser Gly Pro Pro Ala Lys Ala Lys 
1               5                   


<210>  2
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  2

Ser Ser Gln Pro Ser Pro Ser Gly Pro Lys 
1               5                   10  


<210>  3
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  3

Ser Ser Gln Pro Ser Pro Ser Asp Pro Lys 
1               5                   10  


<210>  4
<211>  26
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  4

Ala Ser Gly Pro Pro Ala Lys Ala Lys Glu Thr Gly Lys Arg Lys Ser 
1               5                   10                  15      


Ser Ser Gln Pro Ser Pro Ser Gly Pro Lys 
            20                  25      


<210>  5
<211>  26
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  5

Ala Ser Gly Pro Pro Ala Lys Ala Lys Glu Thr Gly Lys Arg Lys Ser 
1               5                   10                  15      


Ser Ser Gln Pro Ser Pro Ser Asp Pro Lys 
            20                  25      


<210>  6
<211>  32
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  6

Met Ser Pro Lys Pro Arg Ala Ser Gly Pro Pro Ala Lys Ala Lys Glu 
1               5                   10                  15      


Thr Gly Lys Arg Lys Ser Ser Ser Gln Pro Ser Pro Ser Gly Pro Lys 
            20                  25                  30          


<210>  7
<211>  32
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  7

Met Ser Pro Lys Pro Arg Ala Ser Gly Pro Pro Ala Lys Ala Lys Glu 
1               5                   10                  15      


Thr Gly Lys Arg Lys Ser Ser Ser Gln Pro Ser Pro Ser Asp Pro Lys 
            20                  25                  30          


<210>  8
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  8

Arg Ala Ser Gly Pro Pro Ala Lys Ala 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  9

Ala Lys Ala Lys Glu Thr Gly Lys Arg 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  10

Lys Gly Ala Ala Thr Lys Met Ala Ala 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  11

Gly Ala Ala Thr Lys Met Ala Ala Val 
1               5                   


<210>  12
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  12

Met Ser Pro Lys Pro Arg Ala Ser Gly Pro Pro Ala Lys Ala Lys 
1               5                   10                  15  


<210>  13
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  13

Ser Gly Pro Pro Ala Lys Ala Lys Glu Thr Gly Lys Arg Lys Ser 
1               5                   10                  15  


<210>  14
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  14

Pro Ala Lys Ala Lys Glu Thr Gly Lys Arg Lys Ser Ser Ser Gln 
1               5                   10                  15  


<210>  15
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic amino acid

<400>  15

Gly Arg Arg Gly Lys Lys Gly Ala Ala Thr Lys Met Ala Ala Val 
1               5                   10                  15  


